Showing results (251-260 of 652) with videos related to

Sort By:
Pageof 66
JMIR Medical Informatics|August 25, 2023
Comparing Natural Language Processing and Structured Medical Data to Develop a Computable Phenotype for Patients Hospitalized Due to COVID-19: Retrospective AnalysisFeier Chang, Jay Krishnan, Jillian H Hurst, et al.
Infectious Disease Clinics of North America|May 22, 2016
Agents of Last Resort: Polymyxin ResistanceKeith S Kaye, Jason M Pogue, Thien B Tran, et al.
Future Microbiology|March 1, 2024
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumanniiSarah M McLeod, John P O'Donnell, Navaneeth Narayanan, et al.
Pharmacotherapy|March 7, 2012
Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohortRavina Kullar, Susan L Davis, Thomas N Taylor, et al.
Emerging Infectious Diseases|April 14, 2004
Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogensMitchell J Schwaber, Sara E Cosgrove, Howard S Gold, et al.
Infection Control and Hospital Epidemiology|January 21, 2014
Readmissions after diagnosis of surgical site infection following knee and hip arthroplastyKyle G Miletic, Thomas N Taylor, Emily T Martin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 29, 2022
Use of Statistical Process Control Methods for Early Detection of Healthcare Facility-Associated Nontuberculous Mycobacteria Outbreaks: A Single-Center Pilot StudyArthur W Baker, Ahmed Maged, Salah Haridy, et al.
American Journal of Infection Control|May 1, 2016
Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: Focus on clinical trialsDavid J Weber, William A Rutala, Deverick J Anderson, et al.
Infection Control and Hospital Epidemiology|January 4, 2008
Measuring acceptable treatment failure rates for community-acquired pneumonia: potential for reducing duration of treatment and antimicrobial resistanceKeith S Kaye, Anthony D Harris, Jay R McDonald, et al.
Infection and Drug Resistance|September 27, 2018
Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant EnterobacteriaceaeLindsay A Petty, Oryan Henig, Twisha S Patel, et al.
Pageof 66